These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23362524)

  • 1. Venous thromboembolism in cancer clinical trials: recommendation for standardized reporting and analysis.
    Carrier M; Khorana AA; Zwicker JI; Lyman GH; Le Gal G; Lee AY;
    J Thromb Haemost; 2012 Dec; 10(12):2599-601. PubMed ID: 23362524
    [No Abstract]   [Full Text] [Related]  

  • 2. The incidence of venous thromboembolism in cancer patients: a real-world analysis.
    Lyman GH
    Clin Adv Hematol Oncol; 2012 Jan; 10(1):40-2. PubMed ID: 22398806
    [No Abstract]   [Full Text] [Related]  

  • 3. [Venous thromboembolism and cancer].
    Descourt R; Jezequel P; Couturaud F; Leroyer C; Girard P
    Rev Pneumol Clin; 2008 Dec; 64(6):282-9. PubMed ID: 19084207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).
    Imberti D; Di Nisio M; Donati MB; Falanga A; Ghirarduzzi A; Guarneri D; Piovella F; Santoro RC; Baldini E; Zampogna S;
    Thromb Res; 2009 Nov; 124(5):e32-40. PubMed ID: 19744700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on venous thromboembolism in cancer.
    Streiff MB
    J Natl Compr Canc Netw; 2013 Nov; 11(11):1303-4. PubMed ID: 24225964
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of venous thromboembolism in cancer patients: ESMO clinical recommendations.
    Mandalà M; Falanga A; Roila F;
    Ann Oncol; 2008 May; 19 Suppl 2():ii126-7. PubMed ID: 18456750
    [No Abstract]   [Full Text] [Related]  

  • 7. Venous thromboembolism in cancer: what is the optimal treatment?
    Posner J; Rizzolo D
    JAAPA; 2011 Aug; 24(8):44-9. PubMed ID: 21850919
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines.
    Mandalà M; Falanga A; Roila F;
    Ann Oncol; 2011 Sep; 22 Suppl 6():vi85-92. PubMed ID: 21908511
    [No Abstract]   [Full Text] [Related]  

  • 9. Simplicity versus complexity: an existential dilemma as risk tools evolve.
    Khorana AA
    Lancet Haematol; 2018 Jul; 5(7):e273-e274. PubMed ID: 29885941
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of vena cava filters for the management of cancer-related venous thromboembolism: Systematic review and meta-analysis.
    Rojas-Hernandez CM; Zapata-Copete JA; García-Perdomo HA
    Crit Rev Oncol Hematol; 2018 Oct; 130():44-50. PubMed ID: 30196911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism (VTE) in cancer patients. ESMO clinical recommendations for prevention and management.
    Mandalà M; Labianca R;
    Thromb Res; 2010 Apr; 125 Suppl 2():S117-9. PubMed ID: 20433989
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk stratification for cancer-associated venous thromboembolism.
    Connolly GC; Khorana AA
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):35-47. PubMed ID: 19285271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombosis and cancer: Awareness of private practitioners and patients in Poitou-Charentes, a French region].
    Ferru A; Belhadj R; Chapelle G; Berrard C; Bregere JP; Varlet I; Morin C; Marouby D; Buors M; Ducrocq JL; Lechuga P
    J Med Vasc; 2018 May; 43(3):182-192. PubMed ID: 29754728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polish guidelines for the prevention and treatment of venous thromboembolism. 2012 update].
    Zawilska K; Bała MM; Błędowski P; Chmielewski DW; Dobrowolski Z; Frączek M; Frołow M; Gajewski P; Guzik T; Jaeschke R; Korman T; Kotarski J; Kozubski W; Krawczyk M; Kruszewski W; Kulikowski J; Kutaj-Wąsikowska H; Mayzner-Zawadzka E; Mrozikiewicz PM; Musiał J; Niżankowski R; Pasierski T; Poręba R; Tomkowski W; Torbicki A; Undas A; Urbanek T; Wojtukiewicz MZ; Woroń J; Wroński J;
    Pol Arch Med Wewn; 2012; 122 Suppl 2():3-74. PubMed ID: 23385605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of venous thromboembolism in cancer patients: ESMO clinical recommendations.
    Mandalà M; Falanga A; Roila F;
    Ann Oncol; 2009 May; 20 Suppl 4():182-4. PubMed ID: 19454449
    [No Abstract]   [Full Text] [Related]  

  • 16. Biomarkers of venous thromboembolism in cancer: a silent echo from local events?
    Gezelius E; Belting M
    Biomark Med; 2019 May; 13(7):507-509. PubMed ID: 31140831
    [No Abstract]   [Full Text] [Related]  

  • 17. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the management.
    Mandalà M; Falanga A; Roila F;
    Ann Oncol; 2010 May; 21 Suppl 5():v274-6. PubMed ID: 20555096
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current Recommendations for the Prevention and Treatment of Venous Thromboembolism in Cancer Patients].
    Halámková J; Penka M
    Klin Onkol; 2017; 30(2):100-105. PubMed ID: 28397505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of venous thromboembolism on survival in patients with advanced cancer: an unmet clinical need.
    Lyman GH
    Intern Emerg Med; 2014 Aug; 9(5):497-9. PubMed ID: 24858721
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidemiology of cancer-related venous thromboembolism.
    Wun T; White RH
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):9-23. PubMed ID: 19285269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.